HTN risk up for african-american live kidney donors

HTN risk up for african-american live kidney donors
African-American live kidney donors have a significantly increased risk of hypertension compared with non-donors, according to a study published online Oct. 24 in the American Journal of Transplantation.

(HealthDay)—African-American live kidney donors have a significantly increased risk of hypertension compared with non-donors, according to a study published online Oct. 24 in the American Journal of Transplantation.

To examine the risk of hypertension and kidney disease in donors, Mona D. Doshi, M.D., of Wayne State University in Detroit, and associates evaluated 103 African-American live kidney donors, who donated between 1993 and 2006 at two transplant centers, and 235 matched non-donors from the Coronary Artery Risk Development in Young Adults prospective cohort study. Donors and non-donors were followed for a mean of 6.8 or 6.4 years, respectively.

The researchers found that donors had a significantly increased hypertension risk compared with non-donors (40.8 versus 17.9 percent; relative risk, 2.4). Just over half (52.4 percent) of the donors with hypertension were untreated. Of the donors, 15.5 percent had an estimated <60 mL/min/1.73 m², 5.8 percent had microalbuminuria, and none of them were on dialysis.

"The data from our retrospective study demonstrates that live is associated with increased risk of hypertension in African-Americans," the authors write. "At this time, results of the current study should not dissuade African-Americans from being a live , but does raise awareness about the importance of donor follow-up."

One of the authors disclosed financial ties to the pharmaceutical industry.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Never too old to donate a kidney?

Oct 28, 2011

People over age 70 years of age can safely donate a kidney, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results provide good news for patients ...

Recommended for you

Were clinical trial practices in East Germany questionable?

Oct 23, 2014

Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according ...

Schumacher's doctor sees progress after injury

Oct 23, 2014

A French physician who treated Michael Schumacher for nearly six months after the Formula One champion struck his head in a ski accident says he is no longer in a coma and predicted a possible recovery within three years.

User comments